CDC42 and neoplasm: TRPV4 can affect tumor angiogenesis and inflammatory microenvironment [49, 50], intervene in the cytoskeleton-related proteins including RhoA, CDC42, and Rac1 [51, 52], and promote cancer cells EMT.